A study released by Swiss pharmaceutical company Roche in November shows early positive data for new cancer drug atezolizumab, which was used in combination with another drug to treat advanced melanoma.
COVID-19 Update – SERO is open. We continue to consult, evaluate and treat patients and their families at our existing locations.
Posted on November 30, 2015 in News